Article Details

Phase 3 Data Support Enfortumab Vedotin Benefit in Previously Treated Urothelial Carcinoma

Retrieved on: 2021-02-13 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Phase 3 Data Support Enfortumab Vedotin Benefit in Previously Treated Urothelial Carcinoma. View article details on hiswai:

Excerpt

The trial was planned to have 2 analyses, an interim one at 285 deaths (65%) and a final analysis at 439. For the interim analysis, OS was tested with a 1 ...

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up